e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Predictors and triggers of asthma and COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
A. Pillai, A. Turner, R. Stockley (Birmingham, United Kingdom)
Source:
Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Session:
Predictors and triggers of asthma and COPD exacerbations
Session type:
Thematic Poster Session
Number:
787
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Pillai, A. Turner, R. Stockley (Birmingham, United Kingdom). Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification. Eur Respir J 2013; 42: Suppl. 57, 787
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
Symptom/risk assessment in alpha-1-antitrypsin deficiency (AATD) using the 2011 GOLD algorithm
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Symptomatic assessment in COPD GOLD 2011 classification - mMRC/CAT agreement
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014
Does Nutritional Risk Screening 2002 correlate with dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Usefulness of COPD assessment test (CATÔ) for the management of COPD according to GOLD 2011
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
The 2013 updated GOLD strategy: A comparison of the various scenarios
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
COPD: GOLD 2011 and implications for clinical practice
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Defining asthma COPD overlap syndrome (ACOS): A population based study
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept